Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib + Exemestane in Metastatic Breast Cancer
NCT00525096Phase 3Completed
- Sponsor
- ARCAGY
- Start
- Jul 2003
- Primary completion
- Dec 2004
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of celecoxib in breast cancer, sponsored by ARCAGY. Started Jul 2003; status: completed.
02
Drugs
celecoxib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00525096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525096.